253 related articles for article (PubMed ID: 28007045)
1. Observation versus thyroidectomy for papillary thyroid microcarcinoma in the elderly.
Megwalu UC
J Laryngol Otol; 2017 Feb; 131(2):173-176. PubMed ID: 28007045
[TBL] [Abstract][Full Text] [Related]
2. Total Thyroidectomy Versus Lobectomy for the Treatment of Follicular Thyroid Microcarcinoma.
Megwalu UC; Green RW
Anticancer Res; 2016 Jun; 36(6):2899-902. PubMed ID: 27272803
[TBL] [Abstract][Full Text] [Related]
3. Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance.
Lin JF; Jonker PKC; Cunich M; Sidhu SB; Delbridge LW; Glover AR; Learoyd DL; Aniss A; Kruijff S; Sywak MS
Surgery; 2020 Jan; 167(1):110-116. PubMed ID: 31543327
[TBL] [Abstract][Full Text] [Related]
4. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
[No Abstract] [Full Text] [Related]
5. Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients.
Kuo EJ; Roman SA; Sosa JA
Surgery; 2013 Dec; 154(6):1246-53; discussion 1253-4. PubMed ID: 23993409
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching.
Lee J; Park JH; Lee CR; Chung WY; Park CS
Thyroid; 2013 Nov; 23(11):1408-15. PubMed ID: 23509895
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance.
Londero SC; Krogdahl A; Bastholt L; Overgaard J; Trolle W; Pedersen HB; Bentzen J; Schytte S; Christiansen P; Godballe C;
Thyroid; 2013 Sep; 23(9):1159-64. PubMed ID: 23427917
[TBL] [Abstract][Full Text] [Related]
8. Survival impact of treatment options for papillary microcarcinoma of the thyroid.
Lin HW; Bhattacharyya N
Laryngoscope; 2009 Oct; 119(10):1983-7. PubMed ID: 19655332
[TBL] [Abstract][Full Text] [Related]
9. Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching.
Liu Z; Zhao Q; Liu C; Zeng W; Ming J; Chen C; Wang S; Xiong Y; Zhang C; Chen T; Huang T; Guo L
Medicine (Baltimore); 2018 Aug; 97(31):e11791. PubMed ID: 30075609
[TBL] [Abstract][Full Text] [Related]
10. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
11. Impact of extensive neck dissection on survival from papillary thyroid cancer.
Kandil E; Friedlander P; Noureldine S; Islam T; Tufano RP
ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):330-5. PubMed ID: 21997375
[TBL] [Abstract][Full Text] [Related]
12. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
13. Aggressive variants of papillary thyroid microcarcinoma are associated with high-risk features, but not decreased survival.
Holoubek SA; Yan H; Khokar AH; Kuchta KM; Winchester DJ; Prinz RA; Moo-Young TA
Surgery; 2020 Jan; 167(1):19-27. PubMed ID: 31627846
[TBL] [Abstract][Full Text] [Related]
14. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
Brito JP; Ito Y; Miyauchi A; Tuttle RM
Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
[TBL] [Abstract][Full Text] [Related]
15. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
16. Management of incidental and non-incidental papillary thyroid microcarcinoma.
Elliott MS; Gao K; Gupta R; Chua EL; Gargya A; Clark J
J Laryngol Otol; 2013 Jul; 127 Suppl 2():S17-23. PubMed ID: 23544739
[TBL] [Abstract][Full Text] [Related]
17. [Differentiated thyroid carcinoma: survival and prognostic factors].
Sastre Marcos J; Llamazares Iglesias O; Vicente Delgado A; Marco Martínez A; Cánovas Gaillemin B; Orradre Romero JL; Morlan López MÁ; López López J
Endocrinol Nutr; 2011 Apr; 58(4):157-62. PubMed ID: 21419724
[TBL] [Abstract][Full Text] [Related]
18. Paradoxes in thyroid carcinoma treatment: analysis of the SEER database 2010-2013.
Zhou P; Tian S; Li J; Zhao Y; Liu W; Zhang Y; Hu Z
Oncotarget; 2017 Jan; 8(1):345-353. PubMed ID: 27861148
[TBL] [Abstract][Full Text] [Related]
19. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases.
Yu XM; Wan Y; Sippel RS; Chen H
Ann Surg; 2011 Oct; 254(4):653-60. PubMed ID: 21876434
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in papillary thyroid microcarcinoma survival.
Megwalu UC; Saini AT
J Laryngol Otol; 2017 Jan; 131(1):83-87. PubMed ID: 27917722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
